Evgen Pharma Share Discussion Threads

[on target] 02/2/2021 15:34

It does mention funding a clinical trial in glioma.

[bumpa33] 02/2/2021 15:34

Rb - nope, not an issue. I’m over the moon actually. There was no retail involvement, hence the open offer.


Edit: now fully funded through to mid 2023.

[njb67] 02/2/2021 15:30

Doubling of shares in circulation = 50% dilution for shareholders.

Cash for next year or so, but it does not look like it will be sufficient to fund a clinical trial?

[on target] 02/2/2021 15:29

STAR-COVID recruitment has accelerated - on track to hit the 100 by this weekend.

[riggerbeautz] 02/2/2021 15:27

Bumpa it's not really an issue is it mate, we knew it was being played, now they can move on.

[on target] 02/2/2021 15:23

Good RNS all things considered. Huw clearly means business.

[markth126] 02/2/2021 15:22

raising nearly as much as the current market cap of the company! Just shows massive support and as huw says - transformative!!

[on target] 02/2/2021 15:20

Boom there it is.

Kick in the nuts, but could have been worse.

[bumpa33] 02/2/2021 15:18

Maybe next time, you’ll all listen .

[moneymunch] 02/2/2021 07:09

ps kingoaf, you first registered on Advfn 30/7/20 a week before you registered on Lse, with the majority of your posts directed at me and negative on Evgen....Get a life you scumbag troll. Gl ;-)

[moneymunch] 02/2/2021 06:57

Lol kingoaf, 5 and a half times a day under one username , unlike some of the lowlife hiding behind multiple avatars, who troll these share forums. Gl ;-)

[kingalf] 01/2/2021 23:08

And yes Moneymunch the parcel will contain some lube, I can imagine its been quite a sore process removing your mobile from that special safe place on a regular basis.

[kingalf] 01/2/2021 22:58

I've got a fact, Moneymunch has been a member since 27 August 2008 and during this 12 years 5 months and 5 days he has posted 24,745 times.
Approximately 5.4492 times per day.
You seem to have a lot of time on your hands MM, your not serving time are you, what are you in for, come on tell us, you know your amoungst friends.
More then happy to send you a parcel if it helps.

[mikro1] 01/2/2021 22:51

Based on the acceleration of recruitment into their phase 2 trial for Covid, I think that at around the end of Feb they will announce that recruitment is complete - and at that point hopefully the market will sit up and take notice.

[moneymunch] 01/2/2021 21:12

Lol...only 58 , you old b'stard...ha ha ha ;-)

[nobbygnome] 01/2/2021 21:07

Only 58; I retired very early! Ages before I get one....

[moneymunch] 01/2/2021 20:59

Surely you must of had your jab by now??? :-)

[moneymunch] 01/2/2021 20:46

Don't feel down Nobby, you'll get through it...:-)

[nobbygnome] 01/2/2021 20:33

Down again; when is it going to end. Only when MM has finished selling I guess....

[moneymunch] 01/2/2021 19:14

More on those neutrophils , that were highlighted by Prof Chalmers on Friday. Gla :-)

.......

November 2020

An opportunity has arisen for a Research Technician to support our internationally leading lung Infection laboratory at the University of Dundee. The group studies a range of lung infections including COVID-19.

You will be expected to provide high quality technical assistance to Professor Chalmers and the other members of the research team. Core tasks will include processing biological samples, isolating inflammatory cells such as neutrophils and measuring response to treatments using techniques such as ELISA and flow cytometry.

You will support the principal investigator, post-docs and PhD students as part of a multidisciplinary team, performing laboratory research to a high standard, organising study data and supervising undergraduates.

You will work collaboratively with team members to support multiple ongoing research studies including two national COVID-19 studies STOP-COVID ( STAR-COVID 





.....


Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Download PDF Copy

Dr. Liji Thomas, MDBy Dr. Liji Thomas, MDNov 15 2020

Coronavirus disease 2019 (COVID-19) cases continue to rise across the globe. Over 54.3 million people have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative agent of COVID-19 – and 1.31 million have lost their lives.

Scientists in Taiwan recently published a report on their use of anti-neutrophil strategies to treat acute respiratory distress syndrome (ARDS) – a life-threatening condition that can arise in critical COVID-19 cases – in the journal Frontiers in Pediatrics.

[moneymunch] 30/1/2021 20:30

No placing anytime soon Imho, unless Huw has changed the business model without telling us, and as kingalf raised the question of morals ha ha Ha ha...now that is funny, I reckon this has been taken down to shake the tree to get rid of the weak and worried and the short term rabbits, before the significant re-rate happens on the next update....watch this space!!! Gla :-)

[moneymunch] 30/1/2021 20:22

An increase in CD62L(dim) neutrophils precedes the development of pulmonary embolisms in COVID-19 patients

By

 DocWire News Featured Reading

-

 January 22, 2021

[moneymunch] 30/1/2021 20:15

Drugs targeting neutrophils could reduce ARDS in severe COVID-19